Skip to content

13F-HR filed by Tri Locum Partners LP

Tri Locum Partners LP filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 37 holding rows worth $256,000,000.

Accession
0001826434-22-000004
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 37 entries on the cover page, a total value of $256,000,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $256,000,000 with VALUE read as thousands by filing date, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock130,678$20,343,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM769,250$18,216,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock21,477$15,000,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS132,332$13,923,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW383,319$13,056,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock106,790$12,571,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM730,897$12,148,000thousands by filing date
Eli Lilly and Company532457108COM41,610$11,916,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR35,880$11,313,000thousands by filing date
ADICET BIO INC007002108COM523,256$10,449,000thousands by filing date
INHIBRX INC45720L107COM406,733$9,062,000thousands by filing date
Bristol-Myers Squibb Company110122108COM122,817$8,969,000thousands by filing date
IVERIC BIO INC46583P102COM504,371$8,489,000thousands by filing date
STEVANATO GROUP S P A ORD SHST9224W109Stock416,920$8,388,000thousands by filing date
SKINHEALTH SYSTEMS INC88331L108COM CL A493,301$8,327,000thousands by filing date
EVOLENT HEALTH INC CL A30050B101Stock231,499$7,477,000thousands by filing date
EXELIXIS INC COM30161Q104Stock329,068$7,460,000thousands by filing date
CHEMOCENTRYX INC16383L106COM296,327$7,429,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM190,345$7,380,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM1,009,615$6,946,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,447,445$6,434,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM51,750$6,136,000thousands by filing date
PROMETHEUS BIOSCIENCES INC74349U108COM149,066$5,629,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR30,923$5,274,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock170,455$4,348,000thousands by filing date
TRICIDA INC89610F101COM429,383$3,530,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM1,717,589$3,006,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM1,206,897$2,112,000thousands by filing date
FEMASYS INC31447E105cs87,952$199,000thousands by filing date
ANNALY CAPITAL MANAGEMENT035710409COM16,059$113,000thousands by filing date
SIRIUSPOINT LTDG8192H106COM11,488$86,000thousands by filing date
GENWORTH FINL INC37247D106COM SHS15,436$58,000thousands by filing date
CASA SYS INC14713L102COM11,351$51,000thousands by filing date
UWM HOLDINGS CORPORATION COM CL A91823B109Stock10,330$47,000thousands by filing date
INSEEGO CORP45782B104COMMON STOCK10,831$44,000thousands by filing date
AVEANNA HEALTHCARE HLDGS INC05356F105COM10,848$37,000thousands by filing date
SKILLZ INC83067L109COM11,275$34,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001826434-22-000004this filing2022-05-16acceptance time not in the bulk data set